Laboratory Automation Systems and Processes: Global Markets and Technologies Through 2023
The global market for laboratory automation systems and processes should grow from $21.1 billion in 2018 to reach $29.2 billion by 2023 at a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.
- 24 tables
- An overview of the global market and technologies for laboratory automation systems and processes
- Analyses of global market trends, with data from 2017, 2018, and projections of CAGRs through 2023
- Coverage of history and current state of laboratory automation, their types and potential applications
- Discussion about more specialized laboratory automation technologies, such as 3D bioprinting and organoids
- Insight into government regulations and technological issues impacting laboratory automation
- Profiles of major players in the industry, including Abbott Laboratories, Inc., Agilent Technologies, Inc., Bio-Rad, Roche and Thermo Fisher Scientific
Suppliers of laboratory automation will be discussed in terms of market share, product types, and region, where possible. The integration of various product types into various parts of the market will be a focus of the report, given that usage and scale of similar technologies will vary widely among different sectors of the market. Also, regulatory policy will be discussed, as decisions by the Food and Drug Administration (FDA) and other regulatory bodies can drive demand both by approving new uses of technology and by creating market opportunities for companies looking to innovate and reduce laboratory operation costs. Regulatory policies can drive the market penetration of certain products and technologies and, therefore, drive demand.
Specifically excluded from this analysis is the demand for pharmaceuticals, diagnostics, and other laboratory testing outside of the extent to which it generates demand for laboratory automation. Products used in support of laboratory automation, specifically consumables used during laboratory automation, are excluded.
Todd Graham is an experienced scientist who has worked in a variety of settings throughout the biotechnology industry for more than 10 years as a key technical resource for a variety of businesses. Among his accomplishments are coordinating the roll out of a new test for a major clinical laboratory services provider, developing pre-clinical and clinical assays in support of pharmaceuticals and medical devices, and being a key team member in developing novel technologies for molecular diagnostics.